Editorial
The role of biochemical markers of bone turnover in osteoporosis management in clinical practice
- PMID: 17268580
- PMCID: PMC1579290
Item in Clipboard
Editorial
The role of biochemical markers of bone turnover in osteoporosis management in clinical practice
Clin Biochem Rev.
2006 Aug.
No abstract available
Similar articles
-
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.Drugs. 2006;66(16):2031-58. doi: 10.2165/00003495-200666160-00001. Drugs. 2006. PMID: 17112299 Review.
-
Biochemical markers of bone turnover.Curr Opin Nephrol Hypertens. 1999 Jul;8(4):421-7. doi: 10.1097/00041552-199907000-00005. Curr Opin Nephrol Hypertens. 1999. PMID: 10491736 Review.
-
Use of bone turnover markers in the management of osteoporosis.Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):366-372. doi: 10.1097/MED.0000000000000446. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 30299435 Review.
-
Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis.Crit Rev Clin Lab Sci. 2008;45(2):221-58. doi: 10.1080/10408360801949442. Crit Rev Clin Lab Sci. 2008. PMID: 18415816 Review.
-
The use of biochemical markers of bone turnover in osteoporosis.P R Health Sci J. 2007 Jun;26(2):91-5. P R Health Sci J. 2007. PMID: 17722420 Review.
Cited by
-
Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.Osteoporos Int. 2018 May;29(5):1125-1133. doi: 10.1007/s00198-018-4395-y. Epub 2018 Feb 15. Osteoporos Int. 2018. PMID: 29450585 Clinical Trial.
-
Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.PLoS One. 2014 Aug 12;9(8):e103841. doi: 10.1371/journal.pone.0103841. eCollection 2014. PLoS One. 2014. PMID: 25117452 Free PMC article.
-
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).Osteoporos Int. 2012 Jan;23(1):193-9. doi: 10.1007/s00198-011-1561-x. Epub 2011 Feb 25. Osteoporos Int. 2012. PMID: 21350895 Free PMC article.
-
Relationship between Osteopontin and Bone Mineral Density.Acta Endocrinol (Buchar). 2021 Oct-Dec;17(4):509-516. doi: 10.4183/aeb.2021.509. Acta Endocrinol (Buchar). 2021. PMID: 35747863 Free PMC article. Review.
-
Measurement of urinary N-telopeptides and serum C-telopeptides from type I collagen using a lateral flow-based immunoassay.Sensors (Basel). 2012 Dec 24;13(1):165-74. doi: 10.3390/s130100165. Sensors (Basel). 2012. PMID: 23262480 Free PMC article.
References
-
- Seibel MJ, Lang M, Geilenkeuser WJ. Interlaboratory variation of biochemical markers of bone turnover. Clin Chem. 2001;47:1443–50. - PubMed
-
- Guidelines for the management of postmenopausal osteoporosis for GPs. The Royal Australian College Of General Practitioners. (accessed June 30, 2006) http://www.racgp.org.au/document.asp?id=14997
-
- Management of osteoporosis in postmenopausal women: 2006 position statement of the North American Menopause Society. (accessed June 30, 2006) http://www.menopause.org/psosteo.pdf?bcsi_scan_276FAA45874D151E=1 - PubMed
-
- Guideline No 71: Management of Osteoporosis. Scottish Intercollegiate Guidelines Network. (accessed June 30, 2006) http://www.sign.ac.uk/guidelines/fulltext/71/index.html
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources